J.-X. Duan, J. Chem. Soc., Chem. Commun., 1993, 1389–1392;
F. Cottet and M. Schlosser, Eur. J. Org. Chem., 2003, 1559–1568;
I. Nowak and M. J. Robins, J. Org. Chem., 2007, 72, 2678–2681;
G. G. Dubinina, H. Furutachi and D. A. Vicic, J. Am. Chem. Soc.,
2
008, 130, 8600–8601; M. M. Kremlev, W. Tyrra, A. I. Mushta,
D. Naumann and Y. L. Yagupolskii, J. Fluorine Chem., 2010, 131,
12–216; C. P. Zhang, Z. L. Wang, Q. Y. Chen, C. T. Zhang and
Y. C. J. C. Xiao, Angew. Chem., Int. Ed., 2011, 50, 1896–1900;
T. Knauber, F. Arikan, G. V. Roschenthaler and L. J. Gooßen,
2
¨
Fig. 1 Proposed mechanism of aryl trifluoromethylation in micellar
Chem.–Eur. J., 2011, 17, 2689–2697.
9 M. Oishi, H. Kondo and H. Amii, Chem. Commun., 2009,
medium.
1
909–1911.
10 (a) B. S. Samant and S. S. Bhagwat, Appl. Catal., A, 2011, 394,
91–194; (b) D. A. Watson, M. Su, G. Teverovskiy, Y. Zhang,
J. Garcia-Fortanet, T. Kinzel and S. L. Buchwald, Science, 2009,
25, 1661–1664.
synthesis of HCT-116 tumour xenograft for tumour growth
1
inhibition; CF -phenols in the synthesis of anti-measles
9
1
3
20
21
compounds, antihypertensive agents, and inhibitors of multi-
3
22
drug resistance of vincristine pre-treated HeLa-MDR1; etc.
The use of ArBr as starting compounds with no restriction on
the functionality of substrates is especially significant.
1
1 D. A. Culkin and J. F. Hartwig, Organometallics, 2004, 23,
3398–3416; V. V. Grushin and W. J. Marshall, J. Am. Chem.
Soc., 2006, 128, 4632–4641; N. D. Ball, J. W. Kampf and
M. S. Sanford, J. Am. Chem. Soc., 2010, 132, 2878–2879.
2 X. Wang, L. Truesdale and J. Q. Yu, J. Am. Chem. Soc., 2010, 132,
3648–3649.
To understand the effect of micellar head group charges, the
study was conducted using two types of ionic surfactants: an
anionic SDS, linear alkyl benzene sulfonate (LABS) and a cationic
cetyltrimethylammonium bromide (CTAB). However, little
difference was observed on the reaction rates or yields when
using either of these surfactants (Fig. S3, ESIw).
In conclusion, an improved method for converting ArBr
into their corresponding ArCF3 has been developed using
reverse micellar media. The anisotropic palisade layer of SDS
reverse micelles provided an effective oxidative addition reaction
site for LPd and ArBr to form ArLPdBr. The prevention of
1
13 E. J. Cho, T. D. Senecal, T. Kinzel, Y. Zhang, D. A. Watson and
S. L. Buchwald, Science, 2010, 328, 1679–1681.
1
4 B. S. Samant and M. G. Sukhthankar, Bioorg. Med. Chem. Lett.,
011, 21, 1015–1018; B. S. Samant and S. S. Bhagwat,
2
Chin. J. Catal., 2011, 32, 231–234; B. S. Samant and
M. G. Sukhthankar, J. Med. Chem., 2009, 5, 293–300; B. S.
Samant, Y. P. Saraf and S. S. Bhagwat, J. Colloid Interface Sci.,
2
006, 302, 207–213.
1
5 G. W. Kabalka, M. M. Goodman, J. F. Green, R. Marks and
D. Langford, J. Labelled Compd. Radiopharm., 1993, 32, 165;
G. W. Kabalka, J. F. Green, M. M. Goodman, J. T. Maddox
and S. J. Lambert, Radiopharmaceutical synthesis via boronated
polymers, Current Topics in the Chemistry of Boron, ed. G. W.
Kabalka, The Royal Society of Chemistry, Cambridge, UK, 1994,
pp. 199–203; G. W. Kabalka, Z. Wang, J. F. Green and
M. M. Goodman, Appl. Radiat. Isot., 1992, 43, 389–391;
W. Kabalka, V. Namboodiri and M. R. Akula, J. Labelled Compd.
Radiopharm., 2001, 44, 921–929; G. W. Kabalka, J. Labelled
Compd. Radiopharm., 2007, 50, 888–894; G. W. Kabalka, Acc.
Chem. Res., 1984, 17, 215–221; H. M. Schuller and G. W. Kabalka,
US Pat. Appl. Pub., 2 006 067 879, 2006; G. W. Kabalka and
M.-L. Yao, J. Organomet. Chem., 2009, 694, 1638–1641.
(
CH
and the spatial orientation of the ArLPdCF
elimination reaction appear to positively affect the yield of the
desired ArCF products. Overall, the scope of this trifluoro-
3
)
3
SiCF
3
decomposition in the transmetallation reaction
3
during the reductive
3
methylation pathway is wide in that the reaction is successful for
various aromatic compounds containing OH, –CO, –CHO and
2
–NH functionalities.
1
6 J. H. Fendler, E. J. Fendler, G. A. Infante, S. S. Pong and
L. K. Patterson, J. Am. Chem. Soc., 1975, 97, 89–95; C. J. Suckling
and A. A. Wilson, J. Chem. Soc., Perkin Trans. 2, 1981, 12,
1616–1620.
Notes and references
1
K. Muller, C. Faeh and F. Diederich, Science, 2007, 317,
881–1886.
1
2
S. Purser, P. R. Moore, S. Swallow and V. Gouverneur, Chem. Soc.
Rev., 2008, 37, 320–330; A. Kleemann, J. Engel, B. Kutscher and
D. Reichert, Pharmaceutical Substances, Thieme, Stuttgart, 2006.
P. Kirsch, Modern Fluoroorganic Chemistry: Synthesis, Reactivity,
Applications, Wiley-VCH, Weinheim, 2004.
F. Swarts, Bull. Soc. Chim. Belg., 1892, 24, 309–314; G. Valero,
´
X. Companyo and R. Rios, Chem.–Eur. J., 2011, 17, 2018–2037.
T. Umemoto, Chem. Rev., 1996, 96, 1757–1777; S. G. K. Prakash
and A. K. Yudin, Chem. Rev., 1997, 97, 757–786; J.-A. Ma and
D. Cahard, Chem. Rev., 2004, 104, 6119–6146; J.-A. Ma and
D. Cahard, Chem. Rev., 2008, 108, PR1–PR43.
17 A. Hall, S. Atkinson, S. H. Brown, I. P. Chessell, A. Chowdhury,
N. M. Clayton, T. Coleman, G. M. P. Giblin, R. J. Gleave,
B. Hammond, M. P. Healy, M. R. Johnson, A. D. Michel,
A. Naylor, R. Novelli, D. J. Spalding and S. P. Tang, Bioorg.
Med. Chem. Lett., 2006, 16, 3657–3662.
18 B. Peschke, S. Bak, R. Hohlweg, R. Nielsen, D. Viuff and
K. Rimvall, Bioorg. Med. Chem. Lett., 2006, 16, 3162–3165.
19 I. Beria, D. Ballinari, J. A. Bertrand, D. Borghi, R. T. Bossi,
M. G. Brasca, P. Cappella, M. Caruso, W. Ceccarelli,
A. Ciavolella, C. Cristiani, V. Croci, A. De Ponti, G. Fachin,
R. D. Ferguson, J. Lansen, J. K. Moll, E. Pesenti, H. Posteri,
R. Perego, M. Rocchetti, P. Storici, D. Volpi and B. Valsasina,
J. Med. Chem., 2010, 53, 3532–3551.
3
4
5
6
A. P. Stefani, L. Herk and M. Szwarc, J. Am. Chem. Soc., 1961, 83,
4732–4736; J. M. Birchall, G. P. Irvin and R. A. Boyson, J. Chem.
Soc., Perkin Trans. 2, 1975, 435–439; C. S. Rooney, D. C. Remy
and C. A. Hunt, J. Org. Chem., 1983, 48, 3220–3234;
B. R. Langlois, E. Laurent and N. Roidot, Tetrahedron Lett.,
20 A. Sun, A. Prussia, W. Zhan, E. E. Murray, J. Doyle, L.-T. Cheng,
J.-J. Yoon, E. V. Radchenko, V. A. Palyulin, R. W. Compans,
D. C. Liotta, R. K. Plemper and J. P. Snyder, J. Med. Chem., 2006,
49, 5080–5092.
21 F. Touzeau, A. Arrault, G. Guillaumet, E. Scalbert, B. Pfeiffer,
M.-C. Rettori, P. Renard and J.-Y. Merour, J. Med. Chem., 2003,
´
46, 1962–1979.
22 I. Ott, B. Kircher, G. Heinisch and B. Matuszczak, J. Med. Chem.,
2004, 47, 4627–4630.
1
991, 32, 7525–7528.
T. Umemoto and S. Ishihara, Tetrahedron Lett., 1990, 31,
579–3582.
Y. Kobayashi and I. Kumadaki, Tetrahedron Lett., 1969, 10,
095–4096; J. H. Clark, M. A. McClinton and R. J. Blade,
J. Chem. Soc., Chem. Commun., 1988, 638–639; Q.-Y. Chen and
7
8
3
4
7
238 Chem. Commun., 2011, 47, 7236–7238
This journal is c The Royal Society of Chemistry 2011